TBIQYR5066-Global Heparin Market Research Report 2019

                                          
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine
Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin API is an efficient solution to those diseases. 

Raw materials of Heparin API are mainly porcine intestine, bovine lung and bovine intestine, etc. China pig slaughter amount accounted for more than 50% of the world. It has most abundant raw material resources all over the world.

The classification of Heparin includes Heparin Sodium, Heparin Calcium and others, and the proportion of Heparin Sodium in 2016 is about 88%, and the proportion is in decreasing trend from 2012 to 2016.

Heparin is widely used UFH and LMWH. The most proportion of Heparin is used in LMWH, and the proportion in 2016 is 88.9%

Europe is the largest consumption place, with a consumption market share nearly 40% in 2016. Following Europe, United Stated is the second largest consumption place with the consumption market share of 36%. 

Market competition is not intense. Hepalink, Bioibérica, Changshan Pharm, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry. 


The global Heparin market is valued at 990 million US$ in 2018 is expected to reach 1290 million US$ by the end of 2025, growing at a CAGR of 3.4% during 2019-2025.
This report focuses on Heparin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heparin market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Hepalink
    Changshan Pharm
    Qianhong Bio-pharma
    Opocrin
    Pfizer
    Aspen Oss
    King-friend Biochemical Pharmaceutical
    Bioibérica
    Dongcheng Biochemicals
    Jiulong Biochemicals
    Tiandong
    Xinbai
    Yino Pharma Limited
    Deebio

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Heparin Sodium
    Heparin Calcium
    Other

Segment by Application
    UFH
    LMWH